» Articles » PMID: 26317544

KMT Set7/9 Affects Genotoxic Stress Response Via the Mdm2 Axis

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Aug 29
PMID 26317544
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Genotoxic stress inflicted by anti-cancer drugs causes DNA breaks and genome instability. DNA double strand breaks induced by irradiation or pharmacological inhibition of Topoisomerase II activate ATM (ataxia-telangiectasia-mutated) kinase signalling pathway that in turn triggers cell cycle arrest and DNA repair. ATM-dependent gamma-phosphorylation of histone H2Ax and other histone modifications, including ubiquitnylation, promote exchange of histones and recruitment of DNA damage response (DDR) and repair proteins. Signal transduction pathways, besides DDR itself, also control expression of genes whose products cause cell cycle arrest and/or apoptosis thus ultimately affecting the sensitivity of cells to genotoxic stress. In this study, using a number of experimental approaches we provide evidence that lysine-specific methyltransferase (KMT) Set7/9 affects DDR and DNA repair, at least in part, by regulating the expression of an E3 ubiquitin ligase, Mdm2. Furthermore, we show that Set7/9 physically interacts with Mdm2. Several cancer cell lines with inverse expression of Set7/9 and Mdm2 displayed diminished survival in response to genotoxic stress. These findings are signified by our bioinformatics studies suggesting that the unleashed expression of Mdm2 in cancer patients with diminished expression of Set7/9 is associated with poor survival outcome.

Citing Articles

p53: The Multifaceted Roles of Covalent Modifications in Cancer.

Grigoreva T, Romanova A, Tribulovich V, Pestov N, Oganov R, Kovaleva D Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770524 PMC: 11677429. DOI: 10.3390/ph17121682.


Cyproheptadine inhibits in vitro and in vivo lung metastasis and drives metabolic rewiring.

Shannar A, Sarwar M, Dave P, Chou P, Peter R, Xu J Mol Biol Rep. 2024; 51(1):1139.

PMID: 39522095 PMC: 11551078. DOI: 10.1007/s11033-024-10033-6.


A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers.

Olifirenko V, Barlev N Int J Mol Sci. 2024; 25(12).

PMID: 38928301 PMC: 11204235. DOI: 10.3390/ijms25126595.


Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.

Daks A, Parfenyev S, Shuvalov O, Fedorova O, Nazarov A, Melino G Biol Direct. 2024; 19(1):41.

PMID: 38812048 PMC: 11137904. DOI: 10.1186/s13062-024-00484-z.


At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment.

Korneenko T, Pestov N, Nevzorov I, Daks A, Trachuk K, Solopova O Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139802 PMC: 10747911. DOI: 10.3390/ph16121675.


References
1.
Shaltiel I, Aprelia M, Saurin A, Chowdhury D, Kops G, Voest E . Distinct phosphatases antagonize the p53 response in different phases of the cell cycle. Proc Natl Acad Sci U S A. 2014; 111(20):7313-8. PMC: 4034242. DOI: 10.1073/pnas.1322021111. View

2.
Al Rashid S, Dellaire G, Cuddihy A, Jalali F, Vaid M, Coackley C . Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res. 2005; 65(23):10810-21. DOI: 10.1158/0008-5472.CAN-05-0729. View

3.
Masatsugu T, Yamamoto K . Multiple lysine methylation of PCAF by Set9 methyltransferase. Biochem Biophys Res Commun. 2009; 381(1):22-6. DOI: 10.1016/j.bbrc.2009.01.185. View

4.
Branzei D, Foiani M . Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008; 9(4):297-308. DOI: 10.1038/nrm2351. View

5.
Sun Y, Jiang X, Price B . Tip60: connecting chromatin to DNA damage signaling. Cell Cycle. 2010; 9(5):930-6. PMC: 2901859. DOI: 10.4161/cc.9.5.10931. View